TNFSF10 and neoplasm: As evidence, in vivo studies have also shown that the combinatorial therapy (ZD55-TRAIL + SAHA) inhibited tumor growth, as SAHA functioned at the molecular level by preventing the up-regulation of p50 and p65 subunits of the nuclear factor-kB, which has been enhanced by ZD55- TRAIL [248].